MRNA Operating Cash Flow (Statement)
Moderna · Operating Cash Flow (Statement)
MRNA Operating Cash Flow (Statement)
Latest reported-$526.00Mperiod ending
MRNA Quarterly Cash from Operations (-$92.97M → -$526.00M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
MRNA operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -526,000,000 | |
| -630,000,000 | |
| 951,000,000 | |
| -847,000,000 | |
| -919,000,000 | |
| -1,037,000,000 | |
| 825,000,000 | |
| -1,566,000,000 | |
| -1,274,000,000 | |
| -989,000,000 | |
| 622,000,000 | |
| -1,600,000,000 | |
| -915,000,000 | |
| -1,225,000,000 | |
| 1,662,000,000 | |
| 252,000,000 | |
| 304,000,000 | |
| 2,763,000,000 | |
| 3,310,000,000 | |
| 3,276,000,000 | |
| 4,063,000,000 | |
| 2,971,000,000 | |
| 1,264,289,000 | |
| 892,748,000 | |
| -23,875,000 | |
| -106,191,000 | |
| -95,773,000 | |
| -107,048,000 | |
| -112,220,000 | |
| -143,927,000 | |
| -91,020,000 | |
| -80,211,000 | |
| -48,249,000 | |
| -111,385,000 | |
| -102,927,000 | |
| -42,620,000 | |
| -92,968,500 | |
| -92,968,500 |